Scientists concluded from a recent study that those suffering from diabetes who drink daily doses of tea and coffee are at risk of raising their sugar levels.

Experts from the Duke University Medical Center observed ten coffee drinkers who were diagnosed with type 2 diabetes, and keeping their condition in check by getting appropriate amounts of exercise, and having approved diets

A Taiwanese biotechnology company is bringing into the Philippines a possible solution for the glucose tolerance factor lack among Type II diabetics. Tainan-based Maxluck Biotechnology is launching on Thursday the GT and F milk, which helps human cells absorb glucose.

Dr. Frank Mao Chia Hung of Maxluck Biotechnology Corporation explained contrary to common belief that diabetes is an ailment, it is more the inability of the glucose to enter the cells rather than the failure of the pancreas to produce insulin. Using biotechnology he invented an element called trivalent chromium, which helps the glucose enter the cell and be converted as energy, instead of remaining in the blood and causing high blood sugar among Type II diabetics

Sleep disorders topped health complaints among India's outsourcing industry workers, according to a recent survey by Dataquest magazine and technology consulting company IDC.

Call centers and other outsourced businesses employ more than 1.6 million men and women in India, mostly in their 20s and 30s

Researchers concluded from study findings that skipping a meal once a month may prove beneficial to patients, as it may prevent the clogging of arteries.

Observations made from a study in the University of Utah revealed that people who skip a meal every month were found to be 40 percent less likely to be found with clogged arteries, compared to those who did not practice fasting

An experimental drug manufactured by Novo Nordisk yielded a 7 kilogram weight loss for 75 percent of 565 participants. Their weight loss by taking the drug, liraglutide, ranged from 5 to 10 percent.

The experimental medication, produced by the world's biggest insulin maker, is a bio-engineered version of a natural hormone. It stimulates insulin production leading to a feeling of fullness. Novo Nordisk is developing it as a potential treatment for obese and diabetic patients